At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MEDP Medpace
Market Closed 12-27 16:00:00 EST
341.12
-1.80
-0.52%
盘后341.12
+0.000.00%
18:30 EST
High342.57
Low339.00
Vol107.50K
Open341.15
D1 Closing342.92
Amplitude1.04%
Mkt Cap10.58B
Tradable Cap8.68B
Total Shares31.01M
T/O36.64M
T/O Rate0.42%
Tradable Shares25.45M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Truist Financial Issues a Hold Rating on Medpace Holdings (MEDP)
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.